Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-605-2 | CAS number: 53523-90-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- Toxicokinetic Assessment
- Type of information:
- other: Toxicokinetic Assessment
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other:
- Remarks:
- The assessment of the toxicokinetics is based on physico-chemical properties and toxicological data. Experimental toxicokinetic studies were not performed.
Reference
There are no experimental toxicokinetic data available for the substance and this statement is based on the available physico-chemical and toxicological data. This comprises inter alia studies on skin irritation/corrosion, eye irritation, skin sensitization, in vitro mutagenicity and acute and repeated dose oral toxicity. The assumption on toxicokinetics follows the procedure indicated in the “Guidance on information requirements and chemical safety assessment chapter R.7c” of the ECHA guidance document (version 3.0, June 2017).
Description of key information
Key value for chemical safety assessment
Additional information
There are no experimental toxicokinetic data available for the substance and this statement is based on the available physico-chemical and toxicological data. This comprises inter alia studies on skin irritation/corrosion, eye irritation, in vitro mutagenicity and acute and repeated dose oral toxicity. The assumption on toxicokinetics follows the procedure indicated in the “Guidance on information requirements and chemical safety assessment chapter R.7c” of the ECHA guidance document (version 3.0, June 2017).
Available physico-chemical information taken into account:
Physical appearance: Tetralithium 5,5'-(vinylenebis((3-sulphonato-4,1-phenylene)azo))bis(3-methylsalicylate) is marketed as aqueous solution. The substance itself appears as orange to brown solid (powder).
Vapour pressure: Negligible for the solid
Particle size distribution: No data available
Log Pow: -4,04
Molecular weight: 720.4 g/mol
Water solubility: 240 g/L
Estimation of oral absorption: The high molecular weight is not favourable for oral absorption, but the high water solubility contradicts this assumption. Based on the available repeated dose feed study with the substance (OECD guideline 407) an absorption during gastrointestinal passage is indicated by the finding “hyaline droplets” in the rat kidney at the highest concentration tested. This finding is considered to represent a male rat specific systemic effect, thus absorption and distribution of the substance must have previously been occurred.
Estimation of dermal absorption: Dermal absorption is not likely based on the relatively high molecular weight does not favour dermal uptake. Other parameters relevant for dermal absorption: The substance is not irritating to the skin, thus it does not affect the skin barrier.
Estimation of absorption via inhalation: Vapour pressure is considered negligible for the solid. No acute inhalation toxicity study is available to estimate potential absorption via lung.
Overall estimation of absorption: Some absorption is anticipated by oral, dermal and inhalation route.
Estimation of distribution: Based on the high water solubility it is likely that the substance will distribute into the body.
Estimation of accumulation: In general highly water soluble particles have a low potential to accumulate in tissue. Also the log Pow is indicative for a low accumulation potential.
Estimation of metabolism: In vitro genotoxicity data do not indicate the generation of DNA-reactive metabolites due to hepatic biotransformation, since the substance revealed negative results in the available in vitro genotoxicity tests (Ames test, HPRT, MNT in vitro), conducted in the absence and in the presence of a metabolising system.
Estimation of excretion: The finding “hyaline droplets” in the rat kidney revealed in a repeated dose feed study at the highest concentration tested is considered to represent a male rat specific systemic effect, thus urinary excretion is suggested. Also the water solubility is favourable for urinary excretion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
